Mechanisms of obesity-induced inflammation and insulin resistance: Insights into the emerging role of nutritional strategies

Frontiers in Endocrinology

Volumn 4, Issue MAY, 2013, Pages

  McArdle, Maeve A ^a   Finucane, Orla M ^a   Connaughton, Ruth M ^a   McMorrow, Aoibheann M ^a   Roche, Helen M ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Immune cell infiltration; Inflammation; Insulin resistance; Nutrient sensing; Obesity; PUFA

Indexed keywords

ADIPONECTIN; INFLAMMASOME; INTERFERON; INTERLEUKIN 10; MACROPHAGE MIGRATION INHIBITION FACTOR; PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

CELL DAMAGE; CELL DIFFERENTIATION; DENDRITIC CELL; EOSINOPHIL; GENE EXPRESSION; GENETIC POLYMORPHISM; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; HUMAN; IMMUNOMODULATION; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; MACROPHAGE; NATURAL KILLER CELL; OBESITY; PROTEIN DEGRADATION; REVIEW; T LYMPHOCYTE; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE;

EID: 84884193931     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2013.00052     Document Type: Review

References (323)

1. Adams, L. A., Angulo, P., and Lindor, K. D. (2005). Nonalcoholic fatty liver disease. CMAJ 172, 899-905.
2. Akdis, M., Burgler, S., Crameri, R., Eiwegger, T., Fujita, H., Gomez, E., et al. (2011). Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases. J. Allergy Clin. Immunol. 127, 701-721.
3. Alam, I., Ng, T. P., and Larbi, A. (2012). Does inflammation determine whether obesity is metabolically healthy or unhealthy? The aging perspective. Mediators Inflamm. 2012, 456-456.
4. Almeda-Valdes, P., Cuevas-Ramos, D., Mehta, R., Gomez-Perez, F. J., Cruz-Bautista, I., Arellano-Campos, O., et al. (2010). Total and high molecular weight adiponectin have similar utility for the identification of insulin resistance. Cardiovasc. Diabetol. 9, 9-26.
5. Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., et al. (1999). Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257, 79-83.
6. Aso, Y., Yamamoto, R., Wakabayashi, S., Uchida, T., Takayanagi, K., Takebayashi, K., et al. (2006). Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Diabetes 55, 1954-1960.
7. Atsumi, T., Cho, Y. R., Leng, L., McDonald, C., Yu, T., Danton, C., et al. (2007). The proinflammatory cytokine macrophage migration inhibitory factor regulates glucose metabolism during systemic inflammation. J. Immunol. 179, 5399-5406.
8. Azzi, A. (2007). Oxidative stress: a dead end or a laboratory hypothesis? Biochem. Biophys. Res. Commun. 362, 230-232.
9. Bakker, G. C., Van Erk, M. J., Pellis, L., Wopereis, S., Rubingh, C. M., Cnubben, N. H., et al. (2010). An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach. Am. J. Clin. Nutr. 91, 1044-1059.
10. Baron, A. D., Zhu, J. S. H., Weldon, H., Maianu, L., and Garvey, W. T. (1995). Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity. J. Clin. Invest. 96, 2792-2801.
11. Baugh, J. A., and Bucala, R. (2002). Macrophage migration inhibitory factor. Crit. Care Med. 30, S27-S35.
12. Bell, L. N., Ward, J. L., Degawa-Yamauchi, M., Bovenkerk, J. E., Jones, R., Cacucci, B. M., et al. (2006). Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity. Am. J. Physiol. Endocrinol. Metab. 291, E843-E848.
13. Berg, A. H., Combs, T. P., Du, X., Brownlee, M., and Scherer, P. E. (2001). The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7, 947- 953.
14. Bernhagen, J., Krohn, R., Lue, H., Gregory, J. L., Zernecke, A., Koenen, R. R., et al. (2007). MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 13, 587-596.
15. Berraondo, B., and Martínez, J. A. (2000). Free fatty acids are involved in the inverse relationship between hormone-sensitive lipase (HSL) activity and expression in adipose tissue after high-fat feeding or beta3-adrenergic stimulation. Obes. Res. 8, 255-261.
16. Bertola, A., Ciucci, T., Rousseau, D., Bourlier, V., Duffaut, C., Bonnafous, S., et al. (2012). Identification of adipose tissue dendritic cells correlated with obesityassociated insulin-resistance and inducing Th17 responses in mice and patients. Diabetes 61, 2238-2247.
17. Bhattacharya, P., Gopisetty, A., Ganesh, B. B., Sheng, J. R., and Prabhakar, B. S. (2011). GM-CSF-induced, bone-marrow-derived dendritic cells can expand natural Tregs and induce adaptive Tregs by different mechanisms. J. Leukoc. Biol. 89, 235-249.
18. Bjorntorp, P. (1990). "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 10, 493-496.
19. Blok, W. L., Deslypere, J. P., Demacker, P. N., Van der Ven-Jongekrijg, J., Hectors, M. P., Van der Meer, J. W., et al. (1997). Pro- and anti-inflammatory cytokines in healthy volunteers fed various doses of fish oil for 1 year. Eur. J. Clin. Invest. 27, 1003-1008.
20. Boon, J., Hoy, A. J., Stark, R., Brown, R. D., Meex, R. C., Henstridge, D. C., et al. (2013). Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance. Diabetes 62, 401-410.
21. Bortolini, M., Wright, M. B., Bopst, M., and Balas, B. (2013). Examining the safety of PPAR agonists - current trends and future prospects. Expert Opin. Drug Saf. 12, 65-79.
22. Bouwens, M., Bromhaar, M. G., Jansen, J., Mu, M., and Afman, L. A. (2010). Postprandial dietary lipid - specific effects on human peripheral blood mononuclear cell gene expression profiles 1-3. Am. J. Clin. Nutr. 91, 208-217.
23. Bradley, R. L., Fisher, F. F. M., and Maratos-Flier, E. (2008). Dietary fatty acids differentially regulate production of TNF-alpha and IL-10 by murine 3T3-L1 adipocytes. Obesity (Silver Spring) 16, 938-944.
24. Brereton, C. F., Sutton, C. E., Lalor, S. J., Lavelle, E. C., and Mills, K. H. G. (2009). Inhibition of ERK MAPK suppresses IL-23- and IL-1-driven IL-17 production and attenuates autoimmune disease. J. Immunol. 183, 1715-1723.
25. Brigl, M., and Brenner, M. B. (2004). CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22, 817-890.
26. Brochu, M., Tchernof, A., Dionne, I. J., Sites, C. K., Eltabbakh, G. H., Sims, E. A., et al. (2001). What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J. Clin. Endocrinol. Metab. 86, 1020-1025.
27. Brown, M. S., and Goldstein, J. L. (2008). Selective versus total insulin resistance: a pathogenic paradox. Cell Metab. 7, 95-96.
28. Bruning, U., Cerone, L., Neufeld, Z., Fitzpatrick, S. F., Cheong, A., Scholz, C. C., et al. (2011). MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia. Mol. Cell. Biol. 31, 4087-4096.
29. Bruning, U., Fitzpatrick, S. F., Frank, T., Birtwistle, M., Taylor, C. T., and Cheong, A. (2012). NF??B and HIF display synergistic behaviour during hypoxic inflammation. Cell. Mol. Life Sci. 69, 1319-1329.
30. Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., et al. (2005). Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Immunol. 11, 183-190.
31. Calandra, T., Bernhagen, J., Mitchell, R. A., and Bucala, R. (1994). The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. 179, 1895-1902.
32. Calandra, T., and Roger, T. (2003). Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 3, 791-800.
33. Calder, P. C., Ahluwalia, N., Brouns, F., Buetler, T., Clement, K., Cunningham, K., et al. (2011). Dietary factors and low-grade inflammation in relation to overweight and obesity. Br. J. Nutr. 106(Suppl.), S5-S78.
34. Cancello, R., Henegar, C., Viguerie, N., Taleb, S., Poitou, C., Rouault, C., et al. (2005). Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 54, 2277-2286.
35. Carbone, F., La Rocca, C., and Matarese, G. (2012). Immunological functions of leptin and adiponectin. Biochimie 94, 2082-2088.
36. Cárcamo, J. M., Pedraza, A., Bórquez-ojeda, O., Zhang, B., Sanchez, R., Golde, D. W., et al. (2004). Vitamin C is a kinase inhibitor: dehydroascorbic acid inhibits IκBα kinase β. Mol. Cell. Biol. 24, 6645-6652.
37. Cawthorn, W. P., Scheller, E. L., and MacDougald, O. A. (2012). Adipose tissue stem cells meet preadipocyte commitment: going back to the future. J. Lipid Res. 53, 227-246.
38. Chan, M. M. (1995). Inhibition of tumour necrosis factor by curcumin, a phytochemical. Biochem. Pharmacol. 49, 1551-1556.
39. Chavez, J. A., Knotts, T. A., Wang, L. P., Li, G., Dobrowsky, R. T., Florant, G. L., et al. (2003). A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J. Biol. Chem. 278, 10297-10303.
40. Chen, G., and Goeddel, D. V. (2002). TNF-R1 signaling: a beautiful pathway. Science 296, 1634-1635.
41. Chuang, C., Martinez, K., Xie, G., Kennedy, A., Bumrungpert, A., Overman, A., et al. (2010). Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-alpha - mediated inflammation and insulin resistance in primary human adipocytes 1 - 3. Am. J. Clin. Nutr. 92, 1511-1521.
42. Chung, S., Lapoint, K., Martinez, K., Kennedy, A., Boysen Sandberg, M., and McIntosh, M. K. (2006). Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. Endocrinology 147, 5340-5351.
43. Church, T. S., Willis, M. S., Priest, E. L., Lamonte, M. J., Earnest, C. P., Wilkinson, W. J., et al. (2005). Obesity, macrophage migration inhibitory factor, and weight loss. Int. J. Obes. (Lond.) 29, 675-681.
44. Cline, G. W., Petersen, K. F., Krssak, M., Shen, J., Hundal, R. S., Trajanoski, Z., et al. (1999). Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N. Engl. J. Med. 341, 240-246.
45. Codoñer-Franch, P., Valls-Bellés, V., Arilla-Codoñer, A.,and Alonso-Iglesias, E. (2011). Oxidant mechanisms in childhood obesity: the link between inflammation and oxidative stress. Transl. Res. 158, 369-384.
46. Cohen-Lahav, M., Shany, S., Tobvin, D., Chaimovitz, C., and Douvdevani, A. (2006). Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels. Nephrol. Dial. Transplant. 21, 889-897.
47. Conus, F., Allison, D. B., Rabasa-Lhoret, R., St-Onge, M., St-Pierre, D. H., Tremblay-Lebeau, A., et al. (2004). Metabolic and behavioral characteristics of metabolically obese but normal-weight women. J. Clin. Endocrinol. Metab. 89, 5013-5020.
48. Couper, K. N., Blount, D. G., and Riley, E. M. (2008). IL-10: the master regulator of immunity to infection. J. Immunol. 180, 5771-5777.
49. Cua, D. J., and Tato, C. M. (2010). Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 10, 479-489.
50. Curat, C. A., Miranville, A., Sengene, C., Diehl, M., Tonus, C., Busse, R., et al. (2004). From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 53, 1285-1292.
51. Dandona, P., Aljada, A., Ghanim, H., Mohanty, P., Tripathy, C., Hofmeyer, D., et al. (2004). Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin. J. Clin. Endocrinol. Metab. 89, 5043-5047.
52. De Luca, C., and Olefsky, J. M. (2006). Stressed out about obesity and insulin resistance. Nat. Med. 12, 41-42.
53. De Roos, B., Rungapamestry, V., Ross, K., Rucklidge, G., Reid, M., Duncan, G., et al. (2009). Attenuation of inflammation and cellular stress-related pathways maintains insulin sensitivity in obese type I interleukin-1 receptor knockout mice on a high-fat diet. Proteomics 9, 3244-3256.
54. DeFronzo, R. A., and Tripathy, D. (2009). Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care 32(Suppl. 2), S157-S163.
55. Delerive, P., De Bosscher, K., Besnard, S., Vanden Berghe, W., Peters, J. M., Gonzalez, F. J., et al. (1999). Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J. Biol. Chem. 274, 32048-32054.
56. Delerive, P., De Bosscher, K., Vanden, B. W., Fruchart, J., Haegeman, G., and Staels, B. (2002). DNA binding-independent induction of IkBa gene transcription by PPARalpha. Mol. Endocrinol. 16, 1029-1039.
57. DePaolo, R. W., Abadie, V., Tang, F., Fehlner-Peach, H., Hall, J. A., Wang, W., et al. (2011). Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature 471, 220-224.
58. Dinarello, C., Arend, W., Sims, J., Smith, D., Blumberg, H., O'Neill, L., et al. (2010). IL-1 family nomenclature. Nat. Immunol. 11, 973.
59. Dinarello, C. A. (2009). Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27, 519-550.
60. Dong, Z. (2003). Molecular mechanism of the chemopreventive effect of resveratrol. Mutat. Res. 52, 145-150.
61. Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., and Parks, E. J. (2005). Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115, 1343-1351.
62. Dresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., et al. (1999). Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J. Clin. Invest. 103, 253-259.
63. Du, T., Zhou, Z.-G., You, S., Lin, J., Yang, L., Zhou, W.-D., et al. (2009). Regulation by 1, 25-dihydroxy-vitamin D3 on altered TLRs expression and response to ligands of monocyte from autoimmune diabetes. Clin. Chim. Acta 402, 13313-13318.
64. Duthie, G. G., and Wood, A. D. (2011). Natural salicylates: foods, functions and disease prevention. Food Funct. 2, 515-520.
65. Eberl, G., Lees, R., Smiley, S. T., Taniguchi, M., Grusby, M. J., and MacDonald, H. R. (1999). Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J. Immunol. 162, 6410-6419.
66. Ellingsgaard, H., Hauselmann, I., Schuler, B., Habib, A. M., Baggio, L. L., Meier, D. T., et al. (2011). Interleukin-6 enhances insulin secretion by increasing glucagonlike peptide-1 secretion from L cells and alpha cells. Nat. Med. 17, 1481-1489.
67. Exley, M. A., and Koziel, M. J. (2004). To be or not to be NKT: natural killer T cells in the liver. Hepatology 40, 1033-1040.
68. Fantuzzi, G. (2005). Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 115, 911-919.
69. Farrell, G. C., and Larter, C. Z. (2006). Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43, S99-S112.
70. Fasshauer, M., Klein, J., Lossner, U., and Paschke, R. (2003). Interleukin (IL)-6 mRNA expression is stimulated by insulin, isoproterenol, tumour necrosis factor alpha, growth hormone, and IL-6 in 3T3-L1 adipocytes. Horm. Metab. Res. 35, 147-152.
71. Feng, D., Ling, W.-H., and Duan, R.-D. (2010). Lycopene suppresses LPS-induced NO and IL-6 production by inhibiting the activation of ERK, p38MAPK, and NFkappaB in macrophages. Inflamm. Res. 59, 115-121.
72. Ferguson, J. F., Phillips, C. M., Tierney, A. C., Perez-Martinez, P., Defoort, C., Helal, O., et al. (2010). Gene-nutrient interactions in the metabolic syndrome: single nucleotide polymorphisms in ADIPOQ and ADIPOR1 interact with plasma saturated fatty acids to modulate insulin resistance. Am. J. Clin. Nutr. 91, 794-801.
73. Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., et al. (2009). Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 15, 930-939.
74. Figueras, M., Olivan, M., Busquets, S., López-Soriano, F. J., and Argilés, J. M. (2011). Effects of eicosapentaenoic acid (EPA) treatment on insulin sensitivity in an animal model of diabetes: improvement of the inflammatory status. Obesity (Silver Spring) 19, 362-369.
75. Finkel, T., and Holbrook, N. J. (2000). Oxidants, oxidative stress and the biology of ageing. Nature 408, 239-247.
76. Finucane, O. M., Reynolds, C. M., McGillicuddy, F. C., and Roche, H. M. (2012). Insights into the role of macrophage migration inhibitory factor in obesity and insulin resistance. Proc. Nutr. Soc. 71, 622-633.
77. Fischer-Posovszky, P., Kukulus, V., Tews, D., Unterkircher, T., Debatin, K., Fulda, S., et al. (2010). Resveratrol regulates human adipocyte number and function in a Sirt1-dependent manner. Am. J. Clin. Nutr. 92, 5-15.
78. Flachs, P., Rühl, R., Hensler, M., Janovska, P., Zouhar, P., Kus, V., et al. (2011). Synergistic induction of lipid catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie restriction and n-3 fatty acids. Diabetologia 54, 2626-2638.
79. Flegal, K. M., Carroll, M. D., Ogden, C. L., and Johnson, C. L. (2002). Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288, 1723-1727.
80. Forman, B. M., Chen, J., and Evans, R. M. (1997). Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferatoractivated receptors alpha and delta. Proc. Natl. Acad. Sci. U.S.A. 94, 4312-4317.
81. Fujii, N., Jessen, N., and Goodyear, L. J. (2006). AMP-activated protein kinase and the regulation of glucose transport. Am. J. Physiol. Endocrinol. Metab. 291, E867 -E877.
82. Fujisaka, S., Usui, I., Bukhari, A., Ikutani, M., Oya, T., Kanatani, Y., et al. (2009). Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes 58, 2574-2582.
83. Gage, D. (2012). Weight loss/maintenance as an effective tool for controlling type 2 diabetes: novel methodology to sustain weight reduction. Diabetes Metab. Res. Rev. 28, 214-218.
84. Garcia, M. C., Wernstedt, I., Berndtsson, A., Enge, M., Bell, M., Hultgren, O., et al. (2006). Mature-onset obesity in interleukin-1 receptor I knockout mice. Diabetes 55, 1205-1213.
85. Garcia-Diaz, D. F., Campion, J., Quintero, P., Milagro, F. I., Moreno-Aliaga, M. J., and Martinez, J. A. (2011). Vitamin C modulates the interaction between adipocytes and macrophages. Mol. Nutr. Food Res. 55(Suppl. 2), S257-S263.
86. Gautier, E. L., Shay, T., Miller, J., Greter, M., Jakubzick, C., Ivanov, S., et al. (2012). Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 13, 1118-1128.
87. Geissmann, F., Manz, M. G., Jung, S., Sieweke, M. H., Merad, M., and Ley, K. (2010). Development of monocytes, macrophages, and dendritic cells. Science 327, 656 -661.
88. Ghanim, H., Aljada, A., Hofmeyer, D., Syed, T., Mohanty, P., and Dandona, P. (2004). Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 110, 1564-1571.
89. Ghavipour, M., Saedisomeolia, A., Djalali, M., Sotoudeh, G., Eshraghyan, M. R., Malekshahi Moghadam, A., et al. (2012). Tomato juice consumption reduces systemic inflammation in overweight and obese females. Br. J. Nutr. 15, 1-5.
90. Gill, J. M., and Sattar, N. (2009). Ceramides: a new player in the inflammation-insulin resistance paradigm?. Diabetologia 52, 2475-2477.
91. Gonzalez-Baro, M. R., Lewin, T. M., and Coleman, R. A. (2007). Regulation of triglyceride metabolism. II. Function of mitochondrial GPAT1 in the regulation of triacylglycerol biosynthesis and insulin action. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G1195-G1199.
92. Gordon, S. (2003). Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35.
93. Gouranton, E., Thabuis, C., Riollet, C., Malezet-Desmoulins, C., El Yazidi, C., Amiot, M. J., et al. (2011). Lycopene inhibits proinflammatory cytokine and chemokine expression in adipose tissue. J. Nutr. Biochem. 22, 642-648.
94. Granneman, J. G., Li, P., Zhu, Z., and Lu, Y. (2005). Metabolic and cellular plasticity in white adipose tissue I: effects of beta3-adrenergic receptor activation. Am. J. Physiol. Endocrinol. Metab. 289, E608-E616.
95. Gregoire, F. M., Smas, C. M., and Sul, H. S. (1998). Understanding adipocyte differentiation. Physiol. Rev. 78, 783-809.
96. Gual, P., Le Marchand-Brustel, Y., and Tanti, J. F. (2005). Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87, 99- 109.
97. Gulseth, H. L., Gjelstad, I. M. F., Tierney, A. C., Lovegrove, J. A., Defoort, C., Blaak, E. E., et al. (2010). Predict insulin action or secretion in syndrome. Diabetes Care 33, 923-925.
98. Guo, W., Xie, W., Lei, T., and Hamilton, J. A. (2005). Eicosapentaenoic acid, but not oleic acid, stimulates beta-oxidation in adipocytes. Lipids 40, 815-821.
99. Gustafson, B., and Smith, U. (2006). Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes. J. Biol. Chem. 281, 9507-9516.
100. Halberg, N., Khan, T., Trujillo, M. E., Wernstedt-Asterholm, I., Attie, A. D., Sherwani, S., et al. (2009). Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol. Cell 29, 4467-4483.
101. Hammarstedt, A., and Smith, U. (2003). Thiazolidinediones (PPARgamma ligands) increase IRS-1, UCP-2 and C/EBPalpha expression, but not transdifferentiation, in L6 muscle cells. Diabetologia 46, 48-52.
102. Han, L., Zhou, R., Niu, J., McNutt, M. A., Wang, P., and Tong, T. (2010). SIRT1 is regulated by a PPAR{??}-SIRT1 negative feedback loop associated with senescence. Nucleic Acids Res. 38, 7458-7471.
103. Hara, K., Horikoshi, M., Yamauchi, T., Yago, H., Miyazaki, O., Ebinuma, H., et al. (2006). Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 29, 1357-1362.
104. Hare, L. G., Woodside, J. V., and Young, I. S. (2003). Dietary salicylates. J. Clin. Pathol. 56, 649-650.
105. Harford, K. A., Reynolds, C. M., McGillicuddy, F. C., and Roche, H. M. (2011). Fats, inflammation and insulin resistance: insights to the role of macrophage and Tcell accumulation in adipose tissue. Proc. Nutr. Soc. 70, 408-417.
106. Haus, J. M., Kashyap, S. R., Kasumov, T., Zhang, R., Kelly, K. R., Defronzo, R. A., et al. (2009). Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes 58, 337-343.
107. Hawkins, M., Barzilai, N., Liu, R., Hu, M., Chen, W., and Rossetti, L. (1997). Role of the glucosamine pathway in fat-induced insulin resistance. J. Clin. Invest. 99, 2173-2182.
108. He, J., Usui, I., Ishizuka, K., Kanatani, Y., Hiratani, K., Iwata, M., et al. (2006). Interleukin-1alpha inhibits insulin signaling with phosphorylating insulin receptor substrate-1 on serine residues in 3T3-L1 adipocytes. Mol. Endocrinol. 20, 114-124.
109. Heinrich, P. C., Behrmann, I., Haan, S., Hermanns, H. M., Muller-Newen, G., and Schaper, F. (2003). Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 15, 1-20.
110. Hirata, M., Suzuki, M., Ishii, R., Satow, R., Uchida, T., Kitazumi, T., et al. (2011). Genetic defect in phospholipase C??1 protects mice from obesity by regulating thermogenesis and adipogenesis. Diabetes 60, 1926-1937.
111. Hirokawa, J., Sakaue, S., Furuya, Y., Ishii, J., Hasegawa, A., Tagami, S., et al. (1998). Tumor necrosis factor-alpha regulates the gene expression of macrophage migration inhibitory factor through tyrosine kinase-dependent pathway in 3T3-L1 adipocytes. J. Biochem. 123, 733-739.
112. Hirokawa, J., Sakaue, S., Tagami, S., Kawakami, Y., Sakai, M., Nishi, S., et al. (1997). Identification of macrophage migration inhibitory factor in adipose tissue and its induction by tumor necrosis factor-alpha. Biochem. Biophys. Res. Commun. 235, 94-98.
113. Hirosumi, J., Tuncman, G., Chang, L., Gorgun, C. Z., Uysal, K. T., Maeda, K., et al. (2002). A central role for JNK in obesity and insulin resistance. Nature 420, 333- 336.
114. Hoehn, K. L., Salmon, A. B., Hohnen-Behrens, C., Turner, N., Hoy, A. J., Maghzal, G. J., et al. (2009). Insulin resistance is a cellular antioxidant defense mechanism. Proc. Natl. Acad. Sci. U.S.A. 106, 17787-17792.
115. Holland, W. L., Bikman, B. T., Wang, L. P., Yuguang, G., Sargent, K. M., Bulchand, S., et al. (2011). Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J. Clin. Invest. 121, 1858-1870.
116. Hollenberg, C. H., and Vost, A. (1969). Regulation of DNA synthesis in fat cells and stromal elements from rat adipose tissue. J. Clin. Invest. 47, 2485-2498.
117. Hong, E. G., Ko, H. J., Cho, Y. R., Kim, H. J., Ma, Z., Yu, T. Y., et al. (2009). Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle. Diabetes 58, 2525-2535.
118. Hosogai, N., Fukuhara, A., Oshima, K., Miyata, Y., Tanaka, S., Segawa, K., et al. (2007). Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56, 901-911.
119. Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., and Spiegelman, B. M. (1995). Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95, 2409-2415.
120. Hotamisligil, G. S., Budavari, A., Murray, D., and Spiegelman, B. M. (1994). Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J. Clin. Invest. 94, 1543-1549.
121. Hotamisligil, G. S., and Erbay, E. (2008). Nutrient sensing and inflammation in metabolic diseases. Nat. Rev. Immunol. 8, 923-934.
122. Hotamisligil, G. S., Shargill, N. S., and Spiegelman, B. M. (1993). Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87-91.
123. Hotta, K., Bodkin, N. L., Gustafson, T. A., Yoshioka, S., Ortmeyer, H. K., and Hansen, B. C. (1999). Age-related adipose tissue mRNA expression of ADD1/SREBP1, PPARgamma, lipoprotein lipase, and GLUT4 glucose transporter in rhesus monkeys. J. Gerontol. A Biol. Sci. Med. Sci. 54, B183-B188.
124. Ishii-Yonemoto, T., Masuzaki, H., Yasue, S., Okada, S., Kozuka, C., Tanaka, T., et al. (2010). Glucocorticoid reamplification within cells intensifies NF-kappaB and MAPK signaling and reinforces inflammation in activated preadipocytes. Am. J. Physiol. Endocrinol. Metab. 298, E930-E940.
125. Isoda, K., Sawada, S., Ayaori, M., Matsuki, T., Horai, R., Kagata, Y., et al. (2005). Deficiency of interleukin-1 receptor antagonist deteriorates fatty liver and cholesterol metabolism in hypercholesterolemic mice. J. Biol. Chem. 280, 7002-7009.
126. Jacene, H. A., Cohade, C. C., Zhang, Z., and Wahl, R. L. (2011). The relationship between patients' serum glucose levels and metabolically active brown adipose tissue detected by PET/CT. Mol. Imaging Biol. 13, 1278-1283.
127. Jager, J., Gremeaux, T., Cormont, M., Le Marchand-Brustel, Y., and Tanti, J. F. (2007). Interleukin-1beta-induced insulin resistance in adipocytes through downregulation of insulin receptor substrate-1 expression. Endocrinology 148, 241-251.
128. Jellema, A., Plat, J., and Mensink, R. P. (2004). Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state. Eur. J. Clin. Invest. 34, 766-773.
129. Jiang, G., Dallas-Yang, Q., Biswas, S., Li, Z., and Zhang, B. B. (2004). Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor ?? (PPAR??), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo. Biochem. J. 15, 339-346.
130. Jiang, G., Dallas-Yang, Q., Li, Z., Szalkowski, D., Liu, F., Shen, X., et al. (2002). Potentiation of insulin signaling in tissues of Zucker obese rats after acute and longterm treatment with PPARgamma agonists. Diabetes 51, 2412-2419.
131. Joss, A., Akdis, M., Faith, A., Blaser, K., and Akdis, C. A. (2000). IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway. Eur. J. Immunol. 30, 1683-1690.
132. Juge-Aubry, C. E., Somm, E., Giusti, V., Pernin, A., Chicheportiche, R., Verdumo, C., et al. (2003). Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation. Diabetes 52, 1104-1110.
133. Julien, P., Despres, J., and Angel, A. (1989). Scanning electron microscopy of very small fat cells and mature fat cells in human obesity. J. Lipid Res. 30, 293-299.
134. Kabir, M., Skurnik, G., Naour, N., Pechtner, V., Meugnier, E., Rome, S., et al. (2007). Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. Am. J. Clin. Nutr. 86, 1670-1679.
135. Kabon, B., Nagele, A., Reddy, D., Eagon, C., Fleshman, J. W., Sessler, D. I., et al. (2004). Obesity decreases perioperative tissue oxygenation. Anesthesiology 100, 274-280.
136. Karagiannides, I., Tchkonia, T., Dobson, D. E., Steppan, C. M., Cummins, P., Chan, G., et al. (2001). Altered expression of C/EBP family members results in decreased adipogenesis with aging. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R1772-R1780.
137. Karelis, A. D., Faraj, M., Bastard, J.-P., St-Pierre, D. H., Brochu, M., Prud'homme, D., et al. (2005). The metabolically healthy but obese individual presents a favorable inflammation profile. J. Clin. Endocrinol. Metab. 90, 4145-4150.
138. Kelly, M., Gauthier, M.-S., Saha, A. K., and Ruderman, N. B. (2009). Activation of AMP-activated protein kinase by interleukin-6 in rat skeletal muscle: association with changes in cAMP, energy state, and endogenous fuel mobilization. Diabetes 58, 1953-1960.
139. Kern, P. A., Saghizadeh, M., Ong, J. M., Bosch, R. J., Deem, R., and Simsolo, R. B. (1995). The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J. Clin. Invest. 95, 2111-2119.
140. Khan, T., Muise, E. S., Iyengar, P., Wang, Z. V., Chandalia, M., Abate, N., et al. (2009). Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol. Cell. Biol. 29, 1575-1591.
141. Kikly, K., Liu, L., Na, S., and Sedgwick, J. D. (2006). The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation. Curr. Opin. Immunol. 18, 670-675.
142. Kim, G., Kim, J., Ahn, S., Lee, H., and Moon, D. (2004). Lycopene suppresses the lipopolysaccharide-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and nuclear factor-kB. Immunology 113, 203-211.
143. Kinjo, Y., Wu, D., Kim, G., Xing, G., Poles, M. A., Ho, D. D., et al. (2005). Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434, 520-525.
144. Kishore, P., Li, W., Tonelli, J., Lee, D.-E., Koppaka, S., Zhang, K., et al. (2010). Adipocyte-derived factors potentiate nutrient-induced production of plasminogen activator inhibitor-1 by macrophages. Sci. Transl. Med. 2, 20ra15.
145. Kopecky, J., Rossmeisl, M., Flachs, P., Kuda, O., Brauner, P., Jilkova, Z., et al. (2009). n-3 PUFA: bioavailability and modulation of adipose tissue function. Proc. Nutr. Soc. 68, 361-369.
146. Kopelman, P. G. (2000). Obesity as a medical problem. Nature 404, 635-643.
147. Kopp, H.-P., Krzyzanowska, K., Möhlig, M., Spranger, J., Pfeiffer, A. F. H., and Schernthaner, G. (2005). Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. Int. J. Obes. (Lond.) 29, 766-771.
148. Koska, J., Stefan, N., Dubois, S., Trinidad, C., Considine, R. V., Funahashi, T., et al. (2009). mRNA concentrations of MIF in subcutaneous abdominal adipose cells are associated with adipocyte size and insulin action. Int. J. Obes. (Lond.) 33, 842-850.
149. Kosteli, A., Sugaru, E., Haemmerle, G., Martin, J. F., Lei, J., Zechner, R., et al. (2010). Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J. Clin. Invest. 120, 3466-3479.
150. Kováciková, M., Sengenes, C., Kovácová, Z., Šiklová-Vítková, M., Klimcáková, E., Polák, J., et al. (2011). Dietary intervention-induced weight loss decreases macrophage content in adipose tissue of obese women. Int. J. Obes. (Lond.) 35, 91-98.
151. Kowalski, G. M., Nicholls, H. T., Risis, S., Watson, N. K., Kanellakis, P., Bruce, C. R., et al. (2011). Deficiency of haematopoietic-cell-derived IL-10 does not exacerbate high-fat-diet-induced inflammation or insulin resistance in mice. Diabetologia 54, 888-899.
152. Kung, J., and Henry, R. R. (2012). Thiazolidinedione safety. Expert Opin. Drug Saf. 11, 565-579.
153. Lagathu, C., Yvan-Charvet, L., Bastard, J. P., Maachi, M., Quignard-Boulange, A., Capeau, J., et al. (2006). Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes. Diabetologia 49, 2162-2173.
154. Lam, T. K., Yoshii, H., Haber, C. A., Bogdanovic, E., Lam, L., Fantus, I. G., et al. (2002). Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta. Am. J. Physiol. Endocrinol. Metab. 283, E682-E691.
155. Lanthier, N., Molendi-Coste, O., Horsmans, Y., Van Rooijen, N., Cani, P. D., and Leclercq, I. A. (2010). Kupffer cell activation is a causal factor for hepatic insulin resistance. Am. J. Physiol. Gastrointest. Liver Physiol. 298, G107-G116.
156. Lee, S.-H., Ha, H.-S., Park, Y.-J., Lee, J.-H., Yim, H.-W., Yoon, K.-H., et al. (2011). Identifying metabolically obese but normal-weight (MONW) individuals in a nondiabetic Korean population: the Chungju Metabolic disease Cohort (CMC) study. Clin. Endocrinol. (Oxf) 75, 475-481.
157. Liu, H.-S., Chen, Y.-H., Hung, P.-F., and Kao, Y.-H. (2006). Inhibitory effect of green tea (-)-epigallocatechin gallate on resistin gene expression in 3T3-L1 adipocytes depends on the ERK pathway. Am. J. Physiol. Endocrinol. Metab. 290, E273-E281.
158. Lorente-Cebrián, S., Bustos, M., Marti, A., Martinez, J. A., and Moreno-Aliaga, M. J. (2009). Eicosapentaenoic acid stimulates AMP-activated protein kinase and increases visfatin secretion in cultured murine adipocytes. Clin. Sci. 117, 243-249.
159. Lorenzo, M., Fernández-Veledo, S., Vila-Bedmar, R., Garcia-Guerra, L., De Alvaro, C., and Nieto-Vazquez, I. (2008). Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes. J. Anim. Sci. 86, E94-E104.
160. Loscher, C. E., Draper, E., Leavy, O., Kelleher, D., Mills, K. H. G., and Roche, H. M. (2005). Conjugated linoleic acid suppresses NF-kappa B activation and IL-12 production in dendritic cells through ERK-mediated IL-10 induction. J. Immunol. 175, 4990-4998.
161. Lottenberg, A. M., Afonso, M. D. S., Lavrador, M. S. F., Machado, R. M., and Nakandakare, E. R. (2012). The role of dietary fatty acids in the pathology of metabolic syndrome. J. Nutr. Biochem. 23, 1027-1040.
162. Lue, H., Thiele, M., Franz, J., Dahl, E., Speckgens, S., Leng, L., et al. (2007). Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene 26, 5046-5059.
163. Lumeng, C. N., Bodzin, J. L., and Saltiel, A. R. (2007). Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175-184.
164. Lynch, L., Nowak, M., Varghese, B., Clark, J., Hogan, A. E., Toxavidis, V., et al. (2012). Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity 37, 574-587.
165. Lynch, L. A., O'Connell, J. M., Kwasnik, A. K., Cawood, T. J., O'Farrelly, C., and O'Shea, D. B. (2009a). Are natural killer cells protecting the metabolically healthy obese patient?. Obesity (Silver Spring) 17, 601-615.
166. Lynch, L., O'Shea, D., Winter, D. C., Geoghegan, J., Doherty, D. G., and O'Farrelly, C. (2009b). Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity. Eur. J. Immunol. 39, 1893-1901.
167. Mack, I., BelAiba, R. S., Djordjevic, T., Görlach, A., Hauner, H., and Bader, B. L. (2009). Functional analyses reveal the greater potency of preadipocytes compared with adipocytes as endothelial cell activator under normoxia, hypoxia, and TNFalpha exposure. Am. J. Physiol. Endocrinol. Metab. 297, E735-E748.
168. Magkos, F., and Sidossis, L. S. (2007). Recent advances in the measurement of adiponectin isoform distribution. Curr. Opin. Clin. Nutr. Metab. Care 10, 571-575.
169. Maizels, R. M., and Allen, J. E. (2011). Immunology. Eosinophils forestall obesity. Science 332, 186-187.
170. Malozowski, S., Sahlroot, J. T., Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., et al. (2007). Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 357, 302-303.
171. Martin, T. L., Alquier, T., Asakura, K., Furukawa, N., Preitner, F., and Kahn, B. B. (2006). Diet-induced obesity alters AMP kinase activity in hypothalamus and skeletal muscle. J. Biol. Chem. 281, 18933-18941.
172. Masoro, E. J. (2000). Caloric restriction and aging: an update. Exp. Gerontol. 35, 299-305.
173. Mathias, S., Pena, L. A., and Kolesnick, R. N. (1998). Signal transduction of stress via ceramide. Biochem. J. 335(Pt 3), 465-480.
174. Matsuki, T., Horai, R., Sudo, K., and Iwakura, Y. (2003). IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions. J. Exp. Med. 198, 877-888.
175. McEneny, J., Wade, L., Young, I. S., Masson, L., Duthie, G., McGinty, A., et al. (2012). Lycopene intervention reduces inflammation and improves HDL functionality in moderately overweight middle-aged individuals. J. Nutr. Biochem. 1, 163-168.
176. McGillicuddy, F. C., Chiquoine, E. H., Hinkle, C. C., Kim, R. J., Shah, R., Roche, H. M., et al. (2009). Interferon gamma attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway. J. Biol. Chem. 284, 31936-31944.
177. McGillicuddy, F. C., Harford, K. A., Reynolds, C. M., Oliver, E., Claessens, M., Mills, K. H. G., et al. (2011). Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis. Diabetes 60, 1688-1698.
178. McGuirk, P., Higgins, S. C., and Mills, K. H. G. (2005). Regulatory cells and the control of respiratory infection. Curr. Allergy Asthma Rep. 5, 51-55.
179. McLaughlin, T., Sherman, A., Tsao, P., Gonzalez, O., Yee, G., Lamendola, C., et al. (2007). Enhanced proportion of small adipose cells in insulin-resistant vs insulinsensitive obese individuals implicates impaired adipogenesis. Diabetologia 50, 1707-1715.
180. Mills, K. H., and Dunne, A. (2009). Immune modulation: IL-1, master mediator or initiator of inflammation. Nat. Med. 15, 1363-1364.
181. Mitchell, R. A., Liao, H., Chesney, J., Fingerle-Rowson, G., Baugh, J., David, J., et al. (2002). Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc. Natl. Acad. Sci. U.S.A. 99, 345-350.
182. Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., et al. (2003). Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289, 76-79.
183. Moore, K. W., De Waal Malefyt, R., Coffman, R. L., and O'Garra, A. (2001). Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683-765.
184. Mosser, D. M., and Edwards, J. P. (2008). Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969.
185. Moynihan, K. A., Grimm, A. A., Plueger, M. M., Bernal-Mizrachi, E., Ford, E., Cras-Méneur, C., et al. (2005). Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice. Cell Metab. 2, 105-117.
186. Nathan, C. (2003). Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling. J. Clin. Invest. 111, 769-778.
187. Neschen, S., Morino, K., Rossbacher, C., Pongratz, R. L., Cline, G. W., Sono, S., et al. (2006). Fish oil regulates adiponectin secretion by a receptor-y-dependent mechanism in mice. Diabetes 55, 924-928.
188. Netea, M. G., Nold-Petry, C. A., Nold, M. F., Joosten, L. A., Opitz, B., Van der Meer, J. H., et al. (2009). Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 113, 2324-2335.
189. Neyrinck, A. M., Cani, P. D., Dewulf, E. M., De Backer, F., Bindels, L. B., and Delzenne, N. M. (2009). Critical role of Kupffer cells in the management of diet-induced diabetes and obesity. Biochem. Biophys. Res. Commun. 385, 351-356.
190. Nguyen, M. T. A., Favelyukis, S., Nguyen, A.-K. K., Reichart, D., Scott, P. A., Jenn, A., et al. (2007). A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J. Biol. Chem. 282, 35279-35292.
191. Nishimura, S., Manabe, I., Nagasaki, M., Eto, K., Yamashita, H., Ohsugi, M., et al. (2009). CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 15, 914-920.
192. Nishio, M., Yoneshiro, T., Nakahara, M., Suzuki, S., Saeki, K. K., Hasegawa, M., et al. (2012). Production of functional classical brown adipocytes from human pluripotent stem cells using specific hemopoietin cocktail without gene transfer. Cell Metab. 16, 394-406.
193. O'Connell, J., Lynch, L., Cawood, T. J., Kwasnik, A., Nolan, N., Geoghegan, J., et al. (2010). The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity. PLoS ONE 5:e9997. doi:10.1371/journal.pone.0009997
194. O'Connell, J., Lynch, L., Hogan, A., Cawood, T. J., and O'Shea, D. (2011). Preadipocyte factor-1 is associated with metabolic profile in severe obesity. J. Clin. Endocrinol. Metab. 96, E680-E684.
195. Odegaard, J. I., Ricardo-Gonzalez, R. R., Red Eagle, A., Vats, D., Morel, C. R., Goforth, M. H., et al. (2008). Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metab. 7, 496-507.
196. Oh, D. Y., Morinaga, H., Talukdar, S., Bae, E. J., and Olefsky, J. M. (2012). Increased macrophage migration into adipose tissue in obese mice. Diabetes 61, 346-354.
197. Oh, D. Y., Talukdar, S., Bae, E. J., Imamura, T., Morinaga, H., Fan, W., et al. (2010). GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142, 687-698.
198. Oliver, E., McGillicuddy, F. C., Harford, K. A., Reynolds, C. M., Phillips, C. M., Ferguson, J. F., et al. (2012). Docosahexaenoic acid attenuates macrophage-induced inflammation and improves insulin sensitivity in adipocytes-specific differential effects between LC n-3 PUFA. J. Nutr. Biochem. 23, 1192-1200.
199. Orr, J. S., Puglisi, M. J., Ellacott, K. L. J., Lumeng, C. N., Wasserman, D. H., and Hasty, A. H. (2012). Toll-like receptor 4 deficiency promotes the alternative activation of adipose tissue macrophages. Diabetes 61, 2718-2727.
200. Ortega, F. B., Lee, D.-C., Katzmarzyk, P. T., Ruiz, J. R., Sui, X., Church, T. S., et al. (2013). The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur. Heart J. 34, 389-397.
201. Osborn, O., and Olefsky, J. M. (2012). The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med. 18, 363-374.
202. O'Shea, D., Cawood, T. J., O'Farrelly, C., and Lynch, L. (2010). Natural killer cells in obesity: impaired function and increased susceptibility to the effects of cigarette smoke. PLoS ONE 5:e8660. doi:10.1371/journal.pone.0008660
203. Ostrowski, K., Rohde, T., Zacho, M., Asp, S., and Pedersen, B. K. (1998). Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J. Physiol. (Lond.) 508, 949-953.
204. O'Sullivan, A., Balducci, D., Paradisi, F., Cashman, K. D., Gibney, M. J., and Brennan, L. (2011). Effect of supplementation with vitamin D3 on glucose production pathways in human subjects. Mol. Nutr. Food Res. 55, 1018-1025.
205. Ouellet, V., Routhier-Labadie, A., Bellemare, W., Lakhal-Chaieb, L., Turcotte, E., Carpentier, A. C., et al. (2011). Outdoor temperature, age, sex, body mass index, and diabetic status determine the prevalence, mass, and glucose-uptake activity of 18F-FDG-detected BAT in humans. J. Clin. Endocrinol. Metab. 96, 192-199.
206. Park, S. Y., Jeong, K. J., Lee, J., Yoon, D. S., Choi, W. S., Kim, Y. K., et al. (2007). Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol. Cancer Lett. 258, 63-69.
207. Pedersen, B. K. (2011). Muscles and their myokines. J. Exp. Biol. 214, 337-346.
208. Pedersen, B. K., and Febbraio, M. A. (2008). Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol. Rev. 88, 1379-1406.
209. Pedersen, B. K., and Febbraio, M. A. (2012). Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 8, 457-465.
210. Petersen, K. F., and Shulman, G. I. (2002). Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am. J. Cardiol. 90, 11G-18G.
211. Phillips, C., Tierney, A., Perze-Martinez, P., Defoort, C., Blaak, E., Gjelstad, I., et al. (2013). Obesity and body fat classification in the metabolic syndrome: impact on cardiometabolic risk metabotype. Obesity (Silver Spring) 21, E154-E161.
212. Phillips, C. M., Goumidi, L., Bertrais, S., Ferguson, J. F., Field, M. R., Kelly, E. D., et al. (2009a). Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome 1 - 3. Am. J. Clin. Nutr. 90, 1665-1673.
213. Phillips, C. M., Goumidi, L., Bertrais, S., Field, M. R., Peloso, G. M., Shen, J., et al. (2009b). Dietary saturated fat modulates the association between STAT3 polymorphisms and abdominal obesity in adults. J. Nutr. 139, 2011-2017.
214. Pot, G. K., Brouwer, I. A., Enneman, A., Rijkers, G. T., Kampman, E., and Geelen, A. (2009). No effect of fish oil supplementation on serum inflammatory markers and their interrelationships: a randomized controlled trial in healthy, middle-aged individuals. Eur. J. Clin. Nutr. 63, 1353-1359.
215. Poulain-Godefroy, O., and Froguel, P. (2007). Preadipocyte response and impairment of differentiation in an inflammatory environment. Biochem. Biophys. Res. Commun. 356, 662-667.
216. Poulsen, M. M., Vestergaard, P. F., Clasen, B. F., Radko, Y., Christensen, L. P., Stødkilde-Jørgensen, H., et al. (2012). High-dose resveratrol supplementation in obese men. Diabetes 62, 1186-1195.
217. Pricola, K. L., Kuhn, N. Z., Haleem-Smith, H., Song, Y., and Tuan, R. S. (2009). Interleukin-6 maintains bone marrow-derived mesenchymal stem cell stemness by an ERK1/2-dependent mechanism. J. Cell. Biochem. 108, 577-588.
218. Prieur, X., Mok, C. Y. L., Velagapudi, V. R., Núñez, V., Fuentes, L., Montaner, D., et al. (2011). Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes 60, 797-809.
219. Reynolds, C. M., McGillicuddy, F. C., Harford, K. A., Finucane, O. M., Mills, K. H. G., and Roche, H. M. (2012). Dietary saturated fatty acids prime the NLRP3 inflammasome via TLR4 in dendritic cells-implications for diet-induced insulin resistance. Mol. Nutr. Food Res. 56, 1212-1222.
220. Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., and Glass, C. K. (1998). The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391, 79-82.
221. Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., et al. (1996). Mechanism of free fatty acid-induced insulin resistance in humans. J. Clin. Invest. 97, 2859-2865.
222. Roger, T., David, J., Glauser, M. P., and Calandra, T. (2001). MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414, 920- 924.
223. Rossetti, L., Giaccari, A., and DeFronzo, R. A. (1990). Glucose toxicity. Diabetes Care 13, 610-630.
224. Ruan, H., Hacohen, N., Golub, T. R., Van Parijs, L., and Lodish, H. F. (2002). Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory. Diabetes 51, 1319-1336.
225. Ruderman, N. B., Schneider, S. H., and Berchtold, P. (1981). The "metabolically-obese," normal-weight individual. Am. J. Clin. Nutr. 34, 1617-1621.
226. Ruge, T., Lockton, J. A., Renstrom, F., Lystig, T., Sukonina, V., Svensson, M. K., et al. (2009). Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index. Metab. Clin. Exp. 58, 860-866.
227. Saberi, M., Woods, N.-B. B., De Luca, C., Schenk, S., Lu, J. C., Bandyopadhyay, G., et al. (2009). Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metab. 10, 419-429.
228. Sadeghi, K., Wessner, B., Laggner, U., Ploder, M., Tamandl, D., Friedl, J., et al. (2006). Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur. J. Immunol. 36, 361-370.
229. Saghizadeh, M., Ong, J. M., Garvey, W. T., Henry, R. R., and Kern, P. A. (1996). The expression of TNF-a by human muscle. J. Clin. Invest. 97, 1111-1116.
230. Saito, M., Okamatsu-ogura, Y., Matsushita, M., Watanabe, K., Yoneshiro, T., Nio-kobayashi, J., et al. (2009). High incidence of metabolically active brown adipose effects of cold exposure and adiposity. Diabetes 58, 1526-1531.
231. Sallusto, F., and Lanzavecchia, A. (1994). Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor ??. J. Exp. Med. 179, 1109-1118.
232. Sanchez-Zamora, Y., Terrazas, L. I., Vilches-Flores, A., Leal, E., Juárez, I., Whitacre, C., et al. (2010). Macrophage migration inhibitory factor is a therapeutic target in treatment of non-insulin-dependent diabetes mellitus. FASEB J. 24, 2583-2590.
233. Saraiva, M., and O'Garra, A. (2010). The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10, 170-181.
234. Sauter, N. S., Schulthess, F. T., Galasso, R., Castellani, L. W., and Maedler, K. (2008). The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia. Endocrinology 149, 2208-2218.
235. Scheele, C., Nielsen, S., Kelly, M., Broholm, C., Nielsen, A. R., Taudorf, S., et al. (2012). Satellite cells derived from obese humans with type 2 diabetes and differentiated into myocytes in vitro exhibit abnormal response to IL-6. PLoS ONE 7:e39657. doi:10.1371/journal.pone.0039657
236. Schenk, S., Saberi, M., and Olefsky, J. M. (2008). Insulin sensitivity: modulation by nutrients and inflammation. J. Clin. Invest. 118, 2992-3002.
237. Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., and Lodish, H. F. (1995). A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270, 26746-26749.
238. Schipper, H. S., Rakhshandehroo, M., Graaf, S. F. J., Van De Venken, K., Koppen, A., Stienstra, R., et al. (2012). Natural killer T cells in adipose tissue prevent insulin resistance. J. Clin. Invest. 122, 3343-3354.
239. Schottelius, A. J., Mayo, M. W., Sartor, R. B., and Baldwin, A. S. Jr. (1999). Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J. Biol. Chem. 274, 31868-31874.
240. Schwarz, J. M., Linfoot, P., Dare, D., and Aghajanian, K. (2003). Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming highfat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am. J. Clin. Nutr. 77, 43-50.
241. Seppala-Lindroos, A., Vehkavaara, S., Hakkinen, A. M., Goto, T., Westerbacka, J., Sovijarvi, A., et al. (2002). Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J. Clin. Endocrinol. Metab. 87, 3023-3028.
242. Serre-Beinier, V., Toso, C., Morel, P., Gonelle-Gispert, C., Veyrat-Durebex, C., Rohner-Jeanrenaud, F., et al. (2010). Macrophage migration inhibitory factor deficiency leads to age-dependent impairment of glucose homeostasis in mice. J. Endocrinol. 206, 297-306.
243. Sethi, J. K., and Vidal-Puig, A. J. (2007). Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J. Lipid Res. 48, 1253-1262.
244. Seto-Young, D., Avtanski, D., Strizhevsky, M., Parikh, G., Patel, P., Kaplun, J., et al. (2007). Interactions among peroxisome proliferator activated receptor-gamma, insulin signaling pathways, and steroidogenic acute regulatory protein in human ovarian cells. J. Clin. Endocrinol. Metab. 92, 2232-2239.
245. Shi, F. D., Wang, H. B., Li, H., Hong, S., Taniguchi, M., Link, H., et al. (2000). Natural killer cells determine the outcome of B cell-mediated autoimmunity. Nat. Immunol. 1, 245-251.
246. Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., and Flier, J. S. (2006). TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116, 3015-3025.
247. Shin, M.-K., Drager, L. F., Yao, Q., Bevans-Fonti, S., Yoo, D.-Y., Jun, J. C., et al. (2012). Metabolic consequences of high-fat diet are attenuated by suppression of HIF -1??. PLoS ONE 7:e46562. doi:10.1371/journal.pone.0046562
248. Shoelson, S. E., Lee, J., and Yuan, M. (2003). Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int. J. Obes. Relat. Metab. Disord. 27(Suppl. 3), S49-S52.
249. Shulman, G. I. (2000). Cellular mechanisms of insulin resistance. J. Clin. Invest. 106, 171-176.
250. Shulman, G. I., Rothman, D. L., Jue, T., Stein, P., DeFronzo, R. A., and Shulman, R. G. (1990). Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N. Engl. J. Med. 322, 223-228.
251. Singh, S., and Aggarwal, B. B. (1995). Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J. Biol. Chem. 270, 24995-25000.
252. Skurk, T., Herder, C., Kraft, I., Muller-Scholze, S., Hauner, H., and Kolb, H. (2005). Production and release of macrophage migration inhibitory factor from human adipocytes. Endocrinology 146, 1006-1011.
253. Sohal, R. S., Agarwal, S., Candas, M., Forster, M. J., and Lal, H. (1994). Effect of age and caloric restriction on DNA oxidative damage in different tissues of C57BL/6 mice. Mech. Ageing Dev. 76, 215-224.
254. Sohal, R. S., and Weindruch, R. (1996). Oxidative stress, caloric restriction, and aging. Science 273, 59-63.
255. Spranger, J., Kroke, A., Mohlig, M., Hoffmann, K., Bergmann, M. M., Ristow, M., et al. (2003). Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52, 812-817.
256. Steensberg, A., Van Hall, G., Osada, T., Sacchetti, M., Saltin, B., and Klarlund Pedersen, B. (2000). Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J. Physiol. (Lond.) 529, 237-242.
257. Stefan, N., Kantartzis, K., Machann, J., Schick, F., Thamer, C., Rittig, K., et al. (2008). Identification and characterization of metabolically benign obesity in humans. Arch. Intern. Med. 168, 1609-1616.
258. Stefanovic-Racic, M., Yang, X., Turner, M. S., Mantell, B. S., Stolz, D. B., Sumpter, T. L., et al. (2012). Dendritic cells promote macrophage infiltration and comprise a substantial proportion of obesity-associated increases in CD11c+ cells in adipose tissue and liver. Diabetes 61, 2330-2339.
259. Stienstra, R., Duval, C., Müller, M., and Kersten, S. (2007). PPARs, obesity, and inflammation. PPAR Res. 2007, 95974.
260. Stienstra, R., Joosten, L. A., Koenen, T., Van Tits, B., Van Diepen, J. A., Van den Berg, S. A., et al. (2010). The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab. 12, 593-605.
261. Strissel, K. J., DeFuria, J., Shaul, M. E., Bennett, G., Greenberg, A. S., and Obin, M. S. (2010). T-cell recruitment and Th1 polarization in adipose tissue during dietinduced obesity in C57BL/6 mice. Obesity (Silver Spring) 18, 1918-1925.
262. Stylianou, E., and Saklatvala, J. (1998). Interleukin-1. Int. J. Biochem. Cell Biol. 30, 1075-1079.
263. Succurro, E., Marini, M. A., Frontoni, S., Hribal, M. L., Andreozzi, F., Lauro, R., et al. (2008). Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals. Obesity (Silver Spring) 16, 1881-1886.
264. Summers, S. A. (2006). Ceramides in insulin resistance and lipotoxicity. Prog. Lipid Res. 45, 42-72.
265. Sun, C., Zhang, F., Ge, X., Yan, T., Chen, X., Shi, X., et al. (2007). SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab. 6, 307-319.
266. Sun, K., Kusminski, C. M., and Scherer, P. E. (2011). Adipose tissue remodeling and obesity. J. Clin. Invest. 121, 2094-2101.
267. Tack, C. J., Stienstra, R., Joosten, L. A., and Netea, M. G. (2012). Inflammation links excess fat to insulin resistance: the role of the interleukin-1 family. Immunol. Rev. 249, 239-252.
268. Tamura, S., and Shimomura, I. (2005). Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease. J. Clin. Invest. 115, 1139-1142.
269. Thies, F., Masson, L. F., Rudd, A., Vaughan, N., Tsang, C., Brittenden, J., et al. (2012). Effect of a tomato-rich diet on markers of cardiovascular disease risk in moderately overweight, disease-free, middle-aged adults: a randomized controlled trial. Am. J. Clin. Nutr. 95, 1013-1022.
270. Tierney, A., McMonagle, J., Shaw, D. I., Gulseth, H. L., Helal, O., Saris, W. H. M., et al. (2011). Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome - LIPGENE: a European randomized dietary intervention study. Int. J. Obes. (Lond.) 35, 800-809.
271. Tiganis, T. (2011). Reactive oxygen species and insulin resistance: the good, the bad and the ugly. Trends Pharmacol. Sci. 32, 82-89.
272. Tilg, H., and Moschen, A. R. (2008). Inflammatory mechanisms in the regulation of insulin resistance. Mol. Med. 14, 222-231.
273. Timmers, S., Konings, E., Bilet, L., Houtkooper, R. H., Van de Weijer, T., Goossens, G. H., et al. (2011). Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 14, 612-622.
274. Tishinsky, J. M., Ma, D. W. L., and Robinson, L. E. (2011). Eicosapentaenoic acid and rosiglitazone increase adiponectin in an additive and PPAR??-dependent manner in human adipocytes. Obesity (Silver Spring) 19, 262-268.
275. Toh, M. L., Aeberli, D., Lacey, D., Yang, Y., Santos, L. L., Clarkson, M., et al. (2006). Regulation of IL-1 and TNF receptor expression and function by endogenous macrophage migration inhibitory factor. J. Immunol. 177, 4818-4825.
276. Tomlinson, J. W., Moore, J., Cooper, M. S., Bujalska, I., Shahmanesh, M., Burt, C., et al. (2001). Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. Endocrinology 142, 1982-1989.
277. Tsang, J. Y. S., Li, D., Ho, D., Peng, J., Xu, A., Lamb, J., et al. (2011). Novel immunomodulatory effects of adiponectin on dendritic cell functions. Int. Immunopharmacol. 11, 604-609.
278. Tsukumo, D. M. L., Carvalho-Filho, M. A., Carvalheira, J. B. C., Prada, P. O., Hirabara, S. M., Schenka, A. A., et al. (2007). Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56, 1986-1998.
279. Unger, R. (2003). Lipid overload and overflow: metabolic trauma and the metabolic syndrome. Trends Endocrinol. Metab. 14, 398-403.
280. Utzschneider, K. M., and Kahn, S. E. (2006). Review: the role of insulin resistance in nonalcoholic fatty liver disease. J.Clin. Endocrinol. Metab. 91, 4753-4761.
281. Uysal, K. T., Wiesbrock, S. M., Marino, M. W., and Hotamisligil, G. S. (1997). Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389, 610-614.
282. Van Exel, E., Gussekloo, J., De Craen, A. J. M., Frölich, M., Bootsma-Van Der Wiel, A., Westendorp, R. G. J., et al. (2002). Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes: the Leiden 85-Plus Study. Diabetes 51, 1088-1092.
283. Van Marken Lichtenbelt, W. D., Vanhommerig, J. W., Smulders, N. M., Drossaerts, J. M. A. F. L., Kemerink, G. J., Bouvy, N. D., et al. (2009). Cold-activated brown adipose tissue in healthy men. N. Engl. J. Med. 360, 1500-1508.
284. Vandanmagsar, B., Youm, Y.-H. H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., et al. (2011). The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17, 179-188.
285. Varga, T., Czimmerer, Z., and Nagy, L. (2011). PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation. Biochim. Biophys. Acta 1812, 1007-1022.
286. Verschuren, L., Kooistra, T., Bernhagen, J., Voshol, P. J., Ouwens, D. M., Van Erk, M., et al. (2009). MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease. Circ. Res. 105, 99-107.
287. Verstrepen, L., Bekaert, T., Chau, T. L., Tavernier, J., Chariot, A., and Beyaert, R. (2008). TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme. Cell. Mol. Life Sci. 65, 2964-2978.
288. Vijgen, G. H. E. J., Bouvy, N. D., Teule, G. J. J., Brans, B., Schrauwen, P., and Van Marken Lichtenbelt, W. D. (2011). Brown adipose tissue in morbidly obese subjects. PLoS ONE 6:e17247. doi:10.1371/journal.pone.0017247
289. Virtue, S., and Vidal-Puig, A. (2008). It's not how fat you are, it's what you do with it that counts. PLoS Biol. 6:e237. doi:10.1371/journal.pbio.0060237
290. Vozarova, B., Stefan, N., Hanson, R., Lindsay, R. S., Bogardus, C., Tataranni, P. A., et al. (2002). Plasma concentrations of macrophage migration inhibitory factor are elevated in Pima Indians compared to Caucasians and are associated with insulin resistance. Diabetologia 45, 1739-1741.
291. Vozarova, B., Weyer, C., Hanson, K., Tataranni, P. A., Bogardus, C., and Pratley, R. E. (2001). Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes. Res. 9, 414-417.
292. Weatherill, A. R., Lee, J. Y., Zhao, L., Lemay, D. G., Youn, H. S., and Hwang, D. H. (2005). Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. J. Immunol. 174, 5390-5397.
293. Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., and Ferrante, A. W. Jr. (2003). Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808.
294. Weldon, S. M., Mullen, A. C., Loscher, C. E., Hurley, L. A., and Roche, H. M. (2007). Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid. J. Nutr. Biochem. 18, 250-258.
295. Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M. T., et al. (2011). Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 12, 408-415.
296. Wieckowska, A., Papouchado, B. G., Li, Z., Lopez, R., Zein, N. N., and Feldstein, A. E. (2008). Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am. J. Gastroenterol. 103, 1372-1379.
297. Winer, S., Chan, Y., Paltser, G., Truong, D., Tsui, H., Bahrami, J., et al. (2009a). Normalization of obesity-associated insulin resistance through immunotherapy. Nat. Med. 15, 921-929.
298. Winer, S., Paltser, G., Chan, Y., Tsui, H., Engleman, E., Winer, D., et al. (2009b). Obesity predisposes to Th17 bias. Eur. J. Immunol. 39, 2629-2635.
299. Wolfrum, C., Asilmaz, E., Luca, E., Friedman, J. M., and Stoffel, M. (2004). Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature 432, 1027-1032.
300. Wood, A., Baxter, G., Thies, F., Kyle, J., and Duthie, G. (2011). A systematic review of salicylates in foods: estimated daily intake of a Scottish population. Mol. Nutr. Food Res. 55(Suppl. 1), S7-S14.
301. Wu, D., Molofsky, A. B., Liang, H.-E., Ricardo-Gonzalez, R. R., Jouihan, H. A., Bando, J. K., et al. (2011). Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 332, 243-247.
302. Wu, K. K., Sanduja, R., Tsai, A. L., Ferhanoglu, B., and Loose-Mitchell, D. S. (1991). Aspirin inhibits interleukin 1-induced prostaglandin H synthase expression in cultured endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 88, 2384-2387.
303. Xu, J., Morinaga, H., Oh, D., Li, P., Chen, A., Talukdar, S., et al. (2012). GPR105 ablation prevents inflammation and improves insulin sensitivity in mice with dietinduced obesity. J. Immunol. 189, 1992-1999.
304. Xu, X. M., Sansores-Garcia, L., Chen, X. M., Matijevic-Aleksic, N., Du, M., and Wu, K. K. (1999). Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate. Proc. Natl. Acad. Sci. U.S.A. 96, 5292-5297.
305. Xue, B., Yang, Z., Wang, X., and Shi, H. (2012). Omega-3 polyunsaturated fatty acids antagonize macrophage inflammation via activation of AMPK/SIRT1 pathway. PLoS ONE 7:e45990. doi:10.1371/journal.pone.0045990
306. Yadav, P. K., Chen, C., and Liu, Z. (2011). Potential role of NK cells in the pathogenesis of inflammatory bowel disease. J. Biomed. Biotechnol. 2011, 348530.
307. Yamasaki, M., Nagatomo, T., Matsuyama, T., Ikeho, Y., Kato, E., Nishiyama, K., et al. (2012). Conjugated linoleic acids inhibit hypoxia inducible factor-1?? stabilization under hypoxic condition in human hepatocellular carcinoma cells. J. Oleo Sci. 496, 491-496.
308. Yang, F., Oz, H. S., Barve, S., De Villiers, W. J., McClain, C. J., and Varilek, G. W. (2001). The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. Mol. Pharmacol. 60, 528-533.
309. Yang, Z., Hulver, M., McMillan, R. P., Cai, L., Kershaw, E. E., Yu, L., et al. (2012). Regulation of insulin and leptin signaling by muscle suppressor of cytokine signaling 3 (SOCS3). PLoS ONE 7:e47493. doi:10.1371/journal.pone.0047493
310. Yazbeck, R., Howarth, G. S., and Abbott, C. A. (2009). Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?. Trends Pharmacol. Sci. 30, 600-607.
311. Ye, J., Gao, Z., Yin, J., and He, Q. (2007). Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am. J. Physiol. Endocrinol. Metab. 293, E1118-E1128.
312. Yoneshiro, T., Aita, S., Matsushita, M., Okamatsu-Ogura, Y., Kameya, T., Kawai, Y., et al. (2011). Age-related decrease in cold-activated brown adipose tissue and accumulation of body fat in healthy humans. Obesity (Silver Spring) 19, 1755-1760.
313. Yoshino, J., Conte, C., Fontana, L., Mittendorfer, B., Imai, S.-I., Schechtman, K. B., et al. (2012). Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance. Cell Metab. 16, 658-664.
314. Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., et al. (2002). Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277, 50230-50236.
315. Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z. W., Karin, M., et al. (2001). Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293, 1673-1677.
316. Zainal, T. A., Oberley, T. D., Allison, D. B., Szweda, L. I., and Weindruch, R. (2000). Caloric restriction of rhesus monkeys lowers oxidative damage in skeletal muscle. FASEB J. 14, 1825-1836.
317. Zeyda, M., Säemann, M. D., Stuhlmeier, K. M., Mascher, D. G., Nowotny, P. N., Zlabinger, G. J., et al. (2005). Polyunsaturated fatty acids block dendritic cell activation and function independently of NF-kappaB activation. J. Biol. Chem. 280, 14293-14301.
318. Zhang, Q., Tang, X., Lu, Q. Y., Zhang, Z. F., Brown, J., and Le, A. D. (2005). Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells. Mol. Cancer Ther. 4, 1465-1474.
319. Zhong, J., Rao, X., Deiuliis, J., Braunstein, Z., Narula, V., Hazey, J., et al. (2013). A potential role for dendritic cell/macrophage-expressing DPP4 in obesity-induced visceral inflammation. Diabetes 62, 149-157.
320. Zhou, D., Mattner, J., Cantu, C., Schrantz, N., Yin, N., Gao, Y., et al. (2004). Lysosomal glycosphingolipid recognition by NKT cells. Science 306, 1786-1789.
321. Zhu, J., and Paul, W. E. (2008). CD4 T cells: fates, functions, and faults. Blood 112, 1557-1569.
322. Zittermann, S. I., and Issekutz, A. C. (2006). Basic fibroblast growth factor (bFGF, FGF-2) potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule expression. Am. J. Pathol. 168, 835-846.
323. Zuk, P. A., Zhu, M., Mizuno, H., Huang, J., Futrell, J. W., Katz, A. J., et al. (2001). Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7, 211-228.